CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 70 enrolled
Drug / intervention
Restylane Perlane Lidocaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03174132
NCT03174132N/ACompleted

A Randomised, Multi-center, Subject and Evaluator-blinded Study Comparing the Pain and the Safety Profile Associate With Correction of Moderate to Severe Nasolabial Folds Using Restylane Perlane Lidocaine Compared to Restylane Perlane

Galderma R&D·interventional·Posted Jun 2, 2017·Updated Aug 26, 2022

In Brief

A clinical study evaluating Restylane Perlane Lidocaine and Restylane Perlane for Nasolabial Fold. Completed, enrolled 70 participants across 3 sites.

Detailed Summary

The purpose of this study is to evaluate the pain and safety in associated with injection of Restylane Perlane Lidocaine compared to Restylane Perlane using VAS scale

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasolabial Fold
CountriesTaiwan
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 2, 2017
Enrollment StartSep 21, 2017
Primary CompletionJan 16, 2018
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 9.1 years ago

Interventions

Restylane Perlane Lidocainedevice

Intradermal injection

Restylane Perlanedevice

Intradermal injection